High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy

By Lønning P.E.  

Breast Cancer Research and Treatment, Vol. 67, Iss. 2, 2001-05 ,pp. : 111-116

Springer Publishing Company

Access to resources Recommend Favorite

Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer

By Haas R.   Schmid H.   Hahn U.   Hohaus S.   Goldschmidt H.   Murea S.   Kaufmann M.   Wannenmacher M.   Wallwiener D.   Bastert G.   Hunstein W.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 372-378

Elsevier

Access to resources Recommend Favorite

Paclitaxel-containing High-dose Chemotherapy in High-risk Breast Cancer Patients

By Greinix Hildegard T.   Linkesch Werner   Seifert Manfred   Kubista Ernst   Czerwenka Klaus   Elahi Fariborz   Zielinski Christoph   Hoecker Paul   Steger Günther   Schulenburg Axel   Neumeister Geralt   Rabitsch Werner   Jakesz Raimund   Kalhs Peter  

Acta Oncologica, Vol. 39, Iss. 1, 2000-04 ,pp. : 47-52

Informa Healthcare

Access to resources Recommend Favorite

High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: First results of a randomized trial

By Verrill Mark  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 41-43

Informa Healthcare

Access to resources Recommend Favorite

High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers

By Yeh K-H.   Lin M-T.   Lin D-T.   Tang J-L.   Lui L-T.   Lin J-F.   Chang Y-S.   Cheng A-L.   Yu S-C.   Chang K-J.   Chen Y-C.  

Breast Cancer Research and Treatment, Vol. 49, Iss. 3, 1998-06 ,pp. : 237-244

Springer Publishing Company

Access to resources Recommend Favorite